Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous caffeine to accelerate awakening from total intravenous anesthesia
IRCT2016021725600N2Phase 2Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Anesthesia-related recovery impairment (ARRI) comparing Intravenous caffeine with Placebo (2 arms). Primary endpoint: Time to awakening from anesthesia. Started Mar 2016; status: completed.
02
Drugs
caffeine
03
Conditions
Anesthesia-related recovery impairment (ARRI)
Beyond the preview
Go deeper on IRCT2016021725600N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016021725600N2.